The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2V617FVittoria Guerini, Alessandro Rambaldi, Chiara Maria Dellacasa et al.|Leukemia|2007Cited by 151
Selective Targeting of the JAK2V617F Mutation in Polycythemia Vera and Essential Thrombocythemia by ITF2357, a Novel Histone Deacetylase Inhibitor.Vittoria Guerini, Alessandro Rambaldi, Valentina Barbui et al.|Blood|2007Cited by 5